Advertisement

HPLC With Electrochemical and Photodiode Array Detection Analysis of Tocopherol Oxidation and Nitration Products in Human Plasma

  • Kelly S. Williamson
  • Kenneth Hensley
  • Robert A. Floyd
Protocol
Part of the Methods in Pharmacology and Toxicology book series (MIPT)

Abstract

Advances in analytical methodologies in the isolation, characterization, and quantitation of lipid-soluble antioxidants, such as vitamin E, have evolved since its discovery in 1922 (1). The primary purpose of vitamin E (tocopherol) and its tocopherol homologs is to act as free radical scavengers to control lipid oxidation in the body (2). The physiological and biochemical processes lipid-soluble vitamins possess are beneficial in preventing a number of degenerative diseases and conditions such as Alzheimer’s disease and Parkinson’s disease (3, 4, 5, 6, 7), cardiovascular disease (8, 9, 10), and cancer (11, 12, 13). Pharmaceutical, medical, as well as industrial disciplines have been interested in the clinical outcomes of tocopherol studies. Thus, a critical need exists to measure multiple tocopherols and their oxidation products simultaneously in human tissue (2,14, 15, 16, 17, 18, 19). Our laboratory is interested in studying lipid nitration products in biological matrices primarily as biomarkers to determine the level of oxidative stress and tissue damage. 3-Nitrotyrosine has been determined to be a useful protein biomarker employed to measure oxidative stress based in previous publications (20, 21, 22, 23, 24, 25, 26). The most commonly measured nitrated tocopherol compound of interest is 5-NO2-γ-tocopherol (2,19,27,28). This and other tocopherol congeners of interest are depicted in Fig. 1. High performance liquid chromatography (HPLC) with combined electrochemical and photodiode array detection (HPLC-ECD-PDA) is a relatively new, versatile and reliable chromatographic technique employed to generate high sensitivity and selectivity, reproducibility, and accuracy in the determination of tocopherol homologs.
Fig. 1.

The chemical structures of the different tocopherol congeners discussed in the text.

Keywords

High Performance Liquid Chromatography High Performance Liquid Chromatography Grade Nitration Product High Performance Liquid Chromatography Column Tocopherol Homolog 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Serbinova, E. A. and Packer, L. (1994) Antioxidant properties of α-tocopherol and α-tocotrienol. Methods Enzymol. 234, 354–366.PubMedCrossRefGoogle Scholar
  2. 2.
    Hensley, K., Williamson, K. S., and Floyd, R. A. (2000) Measurement of 3-nitrotyrosine and 5-nitro-γ-tocopherol by high-performance liquid chromatography with electrochemical detection. Free Radic. Biol. Med. 28, 520–528.PubMedCrossRefGoogle Scholar
  3. 3.
    Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., et al. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N. Engl. J. Med. 336, 1216–1222.PubMedCrossRefGoogle Scholar
  4. 4.
    Jiménez-Jiménez, F. J., Bustos de, F., Molina, J. A., Benito-León, J., Tallón-Barranco, A., Gasalla, T., et al. (1997) Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer’s disease. J. Neural Transm. 104, 703–710.PubMedCrossRefGoogle Scholar
  5. 5.
    Metcalfe, T., Bowen, D. M., and Muller, D. P. R. (1989) Vitamin E concentrations in human brain of patients with Alzheimer’s disease, fetuses with Down’s syndrome, centenarians, and controls. Neurochem. Res. 14, 1209–1212.PubMedCrossRefGoogle Scholar
  6. 6.
    Grundman, M. (2000) Vitamin E and Alzheimer’s disease: the basis for additional clinical trials. Am. J. Clin. Nutr. 71(suppl), 630S–636S.PubMedGoogle Scholar
  7. 7.
    Adams, Jr., J. D., Klaidman, L. K., Odunze, I. N., Shen, H. C, and Miller, C. A. (1991) Alzheimer’s and Parkinson’s disease: Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol. Chem. Neuropathol. 14, 213–226.PubMedCrossRefGoogle Scholar
  8. 8.
    Janero, D. R. (1991) Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Radic. Biol. Med. 11, 129–144.PubMedCrossRefGoogle Scholar
  9. 9.
    Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G A., and Willett, W.C. (1993) Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328, 1450–1456.PubMedCrossRefGoogle Scholar
  10. 10.
    Armstrong, N. C, Paganga, G., Brunner, E., Miller, N. J., Nanchahal, K., Shipley, M., et al. (1997) Reference values for α-tocopherol and β-carotene in the Whitehall II Study. Free Rad. Res. 27, 207–219.CrossRefGoogle Scholar
  11. 11.
    Gridley, G., McLaughlin, J. K., Block, G., Blot, W.J., Gluch, M., and Fraumeni, Jr., J. F. (1992) Vitamin supplement use and reduce risk of oral and pharyngeal cancer. Am. J. Epidemiol. 135, 1083–1092.PubMedGoogle Scholar
  12. 12.
    Wald, N. J., Boreham, J., Hayward, J. L., and Bulbrook, R. D. (1984) Plasma retinol, β-carotene, and vitamin E levels in relation to the future risk of breast cancer. Br. J. Cancer. 49, 321–324.PubMedCrossRefGoogle Scholar
  13. 13.
    Bostick, R. M., Potter, J. D., McKenzie, D. R., Sellers, T. A., Kushi, L. H., Steinmetz, K. A., and Folsom, A. R. (1993) Reduced risk of colon cancer with high intake of vitamin E: the Iowa’s women health study. Cancer Res. 53, 4230–4237.PubMedGoogle Scholar
  14. 14.
    Simon, E., Paul, J. L., Atger, V., Simon, A., and Moatti, N. (2000) Study of vitamin E net mass transfer between α-tocopherol-enriched HDL and erythrocytes: application to asymptomatic hypercholesterolemic men. Free Radic. Biol. Med. 28, 815–823.PubMedCrossRefGoogle Scholar
  15. 15.
    Schüep, W. and Rettenmaier, R. (1994) Analysis of vitamin E homologs in plasma and tissue: high-performance liquid chromatography. Methods Enzymol. 234, 294–302.PubMedCrossRefGoogle Scholar
  16. 16.
    Zaman, Z., Fielden, P., and Frost, P. G (1993) Simultaneous determination of vitamins A and E and carotenoids in plasma by reverse-phase HPLC in elderly and younger subjects. Clin. Chem. 39, 2229–2234.PubMedGoogle Scholar
  17. 17.
    Stahl, W., Graf, P., Brigelius-Flohé, R., Wechter, W., and Sies, H. (1999) Quantification of the α-and γ-tocopherol metabolites 2,5,7,8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman and 2,7,8-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman in human serum. Anal. Biochem. 275, 254–259.PubMedCrossRefGoogle Scholar
  18. 18.
    Katsanidis, E. and Addis, P. B. (1999) Novel HPLC analysis of tocopherols, tocotrienols, and cholesterol in tissue. Free Radic. Biol. Med. 27, 1137–1140.PubMedCrossRefGoogle Scholar
  19. 19.
    Hensley, K., Williamson, K. S., Maidt, M. L., Gabbita, S. P., Grammas, P., and Floyd, R. A. (1999) Determination of biological oxidative stress using high performance liquid chromatography with electrochemical detection (HPLC-ECD). J. High Res. Chromatogr. 22, 429–437.CrossRefGoogle Scholar
  20. 20.
    Hensley, K., Maidt, M. L., Pye, Q. N., Stewart, C. A., Wack, M., Tabatabaie, T., and Floyd, R. A. (1997) Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihyroxyphenylalanine by high-performance liquid chromatography with electrochemical array detection. Anal. Biochem. 251, 187–195.PubMedCrossRefGoogle Scholar
  21. 21.
    Hensley, K., Maidt, M. L., Yu, Z. Q., Sang, H., Markesbery, W. R., and Floyd, R. A. (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain reveals region-specific accumulation. J. Neurosci. 18, 8126–8132.PubMedGoogle Scholar
  22. 22.
    Maruyama, W., Hashizume, Y., Matsubara, K., and Naoi, M. (1996) Identification of 3-nitro-l-tyrosine, a product of nitric oxide and superoxide, as an indicator of oxidative stress in the human brain. J. Chromatogr. B Biomed. Appl. 676, 153–158.PubMedCrossRefGoogle Scholar
  23. 23.
    Shigenaga, M. K. (1999) Quantitation of protein-bound 3-nitrotyrosine by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 301, 27–40.PubMedCrossRefGoogle Scholar
  24. 24.
    Kaur, H., Lyras, L., Jenner, P., and Halliwell, B. (1998) Artefacts in HPLC detection of 3-nitrotyrosine in human brain tissue. J. Neurochem. 70, 2220–2223.PubMedCrossRefGoogle Scholar
  25. 25.
    Evans, P., Kaur, H., Mitchinson, M. J., and Halliwell, B. (1996) Do human atherosclerotic lesions contain nitrotyrosine. Biochem. Biophys. Res. Commun. 226, 346–351.PubMedCrossRefGoogle Scholar
  26. 26.
    Herce-Pagliai, C., Kotecha, S., and Shuker, D. E. (1998) Analytical Methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review. Nitric Oxide 2, 324–336.PubMedCrossRefGoogle Scholar
  27. 27.
    Cooney, R. V., Harwood, P. J., Franke, A. A., Narala, K., Sundström, A. K., Berggren, P. O., and Mordan, L. J. (1995) Products of γ-tocopherol reaction with NO2 and their formation in rat insulinoma (RINm5F) cells. Free Radic. Biol. Med. 19, 259–269.PubMedCrossRefGoogle Scholar
  28. 28.
    Williamson, K. S., Gabbita, S. P., Mou, S., West, M., Pye, Q. N., Markesbery, W. R., et al. (2002) The nitration product 5-nitro-γ-tocopherol is increased in the Alzheimer brain. Nitric Oxide 6, 221–227.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc.,Totowa, NJ 2003

Authors and Affiliations

  • Kelly S. Williamson
  • Kenneth Hensley
    • 1
  • Robert A. Floyd
    • 2
  1. 1.Free Radical Biology and Aging ProgramOklahoma Medical Research FoundationOklahoma City
  2. 2.Free Radical Biology and Aging ProgramOklahoma Medical Research FoundationOklahoma City

Personalised recommendations